Deccan Health Care Ltd.
Snapshot View

34.55 +0.55 ▲1.6%

31 January 2023, 04:01:00 PM
Volume: 8,400

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.deccanhealthcare.co.in / www.beyoungstore.com
Market Cap 58.88 Cr.
Enterprise Value(EV) 57.47 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.19 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 182.53 Trailing Twelve Months Ending 2022-03
Industry PE 32.54 Trailing Twelve Months Ending 2022-03
Book Value / Share 48.08 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.72 Calculated using Price: 34.55
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.70 Cr. 17,043,180 Shares
FaceValue 10
Company Profile
The Company is engaged in developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products. The Company offers more than 1500 products. These products are used for various purposes such as hair care, skin care, heart care, immunity building etc. The Company offers a long-chain omerga-3 fatty acid, joint health nutrients, diacerein, antioxidants, immune enhancing components, skin ageing products, instant energy drinks, and calcium supplements; and a formula for males. The Company supplies their products in various forms such as tablets, capsules, gel, liquids, ointments, powder, pastes, etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.62%
1 Week
-0.72%
1 Month
-16.44%
3 Month
-28.76%
6 Month
+0.44%
1 Year
+27.73%
2 Year
+33.14%
5 Year
10 Year
2 years 2021-03 2022-03
Return on Equity (%) 0.51 0.42
Return on Capital Employed (%) 0.81 0.89
Return on Assets (%) 0.42 0.35

Balance Sheet View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 77 77
Non Curr. Liab. 3 3
Curr. Liab. 13 10
Minority Int.
Equity & Liab. 92 91
Non Curr. Assets 26 23
Curr. Assets 66 68
Misc. Exp. not W/O
Total Assets 92 91

Profit Loss View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 34 33
Other Income 0 0
Total Income 34 33
Total Expenditure -32 -28
PBIDT 2 6
Interest 0 0
Depreciation -1 -1
Taxation 0 0
Exceptional Items -3
PAT 0 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0
Adjusted EPS 0 0

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 -1
Cash Fr. Inv. 0 0
Cash Fr. Finan. 0 0
Net Change 0 -1
Cash & Cash Eqvt 3 3

Shareholding Pattern View Details >>

9 Qtrs 2018-03 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%)
Promoter 74.51 51.39 51.30 45.61 35.94 35.70 34.89 27.60 22.21
Public 25.49 48.61 48.70 54.39 64.06 64.30 65.11 72.40 77.79
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.08 0.10

Announcements View Details >>

Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 we wish to inform you that the entire holding of DHCL is in dematerialized form and we have not received any dematerialization and re-materialization requests from any of the shareholders of our company during the quarter ended December 31 2022 hence the aforementioned regulation does not apply to our company.
Wed, 07 Dec 2022
Appointment of Company Secretary and Compliance Officer
This is to inform you that the Board of Directors of Deccan Healthcare Limited in their meeting held on 7th December 2022 has appointed Ms. Vaishali Gagnani as the Company Secretary Compliance Officer and Key Managerial Personnel of the Company w.e.f 07th December 2022
Wed, 07 Dec 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held Today 07Th December 2022
As per captioned subject and reference to our Intimation vide letter dated 25th November 2022 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Wednesday December 07 2022 has approved as per Attached Outcome

Technical Scans View Details >>

Tue, 31 Jan 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,331.17 1,034.50 -1.6%
Divi's Laboratories Ltd. 88,067.87 3,315.30 -1.5%
Cipla Ltd. 82,086.54 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. 72,004.82 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. 61,188.28 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. 51,492.78 1,521.45 -1.7%
Abbott India Ltd. 44,288.65 20,785.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.96 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.43 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 31.11 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.72 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.88 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.96 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 50.23 20,785.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.68 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.26 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-12 3.62 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.26 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.22 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.08 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-09 16.32 20,785.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 20,785.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,785.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.50 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,315.30 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,017.00 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,324.15 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,255.55 +0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,521.45 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 20,785.15 -0.9%

FAQ's On Deccan Health Care Ltd.

What is Deccan Health Care share price?

Can I buy Deccan Health Care shares now?

What is the Market Cap of Deccan Health Care?

What are the key metrics to analyse Deccan Health Care?

What is the 52 Week High and Low of Deccan Health Care?

What is the trend of Deccan Health Care share price?